23 May 2013
Keywords: pharmacyclics, initiates, ph, ii, xcytrin, trial, usa
Article | 12 July 2004
Pharmacyclics of the USA says that it is enrolling patients in a PhaseII clinical trial of Xcytrin (motexafin gadolinium) Injection, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2004
5 July 2004
22 May 2013
© 2013 thepharmaletter.com